title: Cefotaxime in the prophylaxis of otorhinolaryngological cancer surgery. Long term versus short term administration, results of a multicentre study.
authors.affiliation: Service ORL, Hôpital Claude Bernard, Paris.
authors.forename: P
authors.initials: P
authors.lastname: Gehanno
authors.forename: N
authors.initials: N
authors.lastname: Moisy
authors.forename: C
authors.initials: C
authors.lastname: Guédon
mesh_terms: D000368:Aged; D002439:Cefotaxime / Q000627:therapeutic use*; D005260:Female; D005602:France; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010039:Otorhinolaryngologic Neoplasms / Q000150:complications / Q000601:surgery*; D011897:Random Allocation; D018805:Sepsis / Q000453:epidemiology; D013530:Surgical Wound Infection / Q000453:epidemiology / Q000517:prevention & control*; D013997:Time Factors
chemical_list: D002439:Cefotaxime